Research programme: osteoporosis therapies - BiologicsMDAlternative Names: parathyroid hormone - BiologicsMD; parathyroid hormone-CBD; parathyroid-hormone-CBD-BiologicsMDS; PTH-CBD
Latest Information Update: 16 Jul 2016
At a glance
- Originator BiologicsMD
- Class Hormones; Proteins
- Mechanism of Action Osteogenesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Osteoporosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoporosis in USA
- 12 Jun 2012 Preclinical trials in Osteoporosis in USA (unspecified route)